Ram Fridlich

Title: Ram Fridlich: Innovator in Age-Related Macular Degeneration Treatment

Introduction

Ram Fridlich is a notable inventor based in Paris, France. He has made significant contributions to the field of ophthalmology, particularly in the treatment of age-related macular degeneration (AMD). His innovative work has the potential to improve the quality of life for many individuals affected by this condition.

Latest Patents

Fridlich holds a patent for "Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD)." This invention focuses on the use of RdCVFL polypeptide or polynucleotide in the treatment of AMD. His research aims to provide effective therapeutic options for patients suffering from this debilitating eye disease.

Career Highlights

Throughout his career, Ram Fridlich has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Fridlich has collaborated with esteemed colleagues, including Thierry Leveillard and Jose-Alain Sahel. These partnerships have enhanced his research efforts and facilitated the development of innovative solutions for AMD.

Conclusion

Ram Fridlich's contributions to the treatment of age-related macular degeneration highlight his dedication to advancing medical science. His patent and collaborations reflect his commitment to improving patient outcomes in ophthalmology.